Genetic Technologies (GENE), University of Melbourne Enter Development Agreement for Colorectal Cancer Risk Assessment Test
Tweet Send to a Friend
Genetic Technologies (NASDAQ: GENE) announced the signing of an exclusive worldwide license agreement with The University of Melbourne for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
